Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8981 |
High Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.8712 |
High Similarity |
NPD6166 |
Phase 2 |
0.8712 |
High Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.8712 |
High Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.8675 |
High Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.8667 |
High Similarity |
NPD5844 |
Phase 1 |
0.85 |
High Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.8494 |
Intermediate Similarity |
NPD7228 |
Approved |
0.8415 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.8393 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.8385 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.8333 |
Intermediate Similarity |
NPD1613 |
Approved |
0.8333 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.8333 |
Intermediate Similarity |
NPD7054 |
Approved |
0.8323 |
Intermediate Similarity |
NPD1934 |
Approved |
0.8293 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.8284 |
Intermediate Similarity |
NPD7472 |
Approved |
0.8272 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.8235 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.8228 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.821 |
Intermediate Similarity |
NPD37 |
Approved |
0.8204 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.8199 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.8187 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.8171 |
Intermediate Similarity |
NPD4966 |
Approved |
0.8171 |
Intermediate Similarity |
NPD4965 |
Approved |
0.8171 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.8144 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.814 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.8121 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.811 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.8107 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.8084 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.8079 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.8067 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.8059 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.8037 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.8035 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.8024 |
Intermediate Similarity |
NPD5494 |
Approved |
0.8012 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.8012 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.8 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.8 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7977 |
Intermediate Similarity |
NPD7240 |
Approved |
0.7963 |
Intermediate Similarity |
NPD1653 |
Approved |
0.7961 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7947 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7941 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.7939 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.7939 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.7939 |
Intermediate Similarity |
NPD2801 |
Approved |
0.7937 |
Intermediate Similarity |
NPD1511 |
Approved |
0.7925 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7895 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.7879 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.784 |
Intermediate Similarity |
NPD1512 |
Approved |
0.7824 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7824 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7797 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7784 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7784 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7771 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7738 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7738 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.7727 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7711 |
Intermediate Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.7697 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7692 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.7692 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.7688 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7679 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7673 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.7673 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.7669 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.7669 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.7667 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7661 |
Intermediate Similarity |
NPD8127 |
Discontinued |
0.7647 |
Intermediate Similarity |
NPD7680 |
Approved |
0.7644 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.764 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.764 |
Intermediate Similarity |
NPD3750 |
Approved |
0.764 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7628 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7625 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.7622 |
Intermediate Similarity |
NPD7237 |
Clinical (unspecified phase) |
0.761 |
Intermediate Similarity |
NPD6100 |
Approved |
0.761 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7607 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.76 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.7588 |
Intermediate Similarity |
NPD3749 |
Approved |
0.758 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7576 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7576 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7564 |
Intermediate Similarity |
NPD6233 |
Phase 2 |
0.7562 |
Intermediate Similarity |
NPD7266 |
Discontinued |
0.7528 |
Intermediate Similarity |
NPD7549 |
Discontinued |
0.75 |
Intermediate Similarity |
NPD6799 |
Approved |
0.7486 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7484 |
Intermediate Similarity |
NPD7097 |
Phase 1 |
0.7472 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.7469 |
Intermediate Similarity |
NPD6674 |
Discontinued |
0.7468 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7455 |
Intermediate Similarity |
NPD5401 |
Approved |
0.744 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.7438 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7434 |
Intermediate Similarity |
NPD1608 |
Approved |
0.7419 |
Intermediate Similarity |
NPD2861 |
Phase 2 |
0.7407 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.7403 |
Intermediate Similarity |
NPD2797 |
Approved |
0.7389 |
Intermediate Similarity |
NPD3268 |
Approved |
0.7371 |
Intermediate Similarity |
NPD7782 |
Clinical (unspecified phase) |
0.7371 |
Intermediate Similarity |
NPD7783 |
Phase 2 |
0.7362 |
Intermediate Similarity |
NPD1652 |
Phase 2 |
0.7358 |
Intermediate Similarity |
NPD8151 |
Discontinued |
0.7349 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7349 |
Intermediate Similarity |
NPD2532 |
Approved |
0.7349 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7346 |
Intermediate Similarity |
NPD6006 |
Clinical (unspecified phase) |
0.7346 |
Intermediate Similarity |
NPD6002 |
Phase 3 |
0.7346 |
Intermediate Similarity |
NPD6005 |
Phase 3 |
0.7346 |
Intermediate Similarity |
NPD6004 |
Phase 3 |
0.7346 |
Intermediate Similarity |
NPD6003 |
Clinical (unspecified phase) |
0.7341 |
Intermediate Similarity |
NPD919 |
Approved |
0.7329 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.7329 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7325 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.7317 |
Intermediate Similarity |
NPD4110 |
Phase 3 |
0.7317 |
Intermediate Similarity |
NPD4109 |
Clinical (unspecified phase) |
0.7317 |
Intermediate Similarity |
NPD8166 |
Discontinued |
0.7284 |
Intermediate Similarity |
NPD2796 |
Approved |
0.7284 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7278 |
Intermediate Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.7278 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7278 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7268 |
Intermediate Similarity |
NPD8150 |
Discontinued |
0.7256 |
Intermediate Similarity |
NPD5698 |
Clinical (unspecified phase) |
0.7253 |
Intermediate Similarity |
NPD7090 |
Clinical (unspecified phase) |
0.7237 |
Intermediate Similarity |
NPD17 |
Approved |
0.7234 |
Intermediate Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.7226 |
Intermediate Similarity |
NPD3225 |
Approved |
0.7219 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.7215 |
Intermediate Similarity |
NPD7095 |
Approved |
0.7202 |
Intermediate Similarity |
NPD6273 |
Approved |
0.7178 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7178 |
Intermediate Similarity |
NPD2438 |
Suspended |
0.7161 |
Intermediate Similarity |
NPD4749 |
Approved |
0.716 |
Intermediate Similarity |
NPD7427 |
Discontinued |
0.7143 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.7134 |
Intermediate Similarity |
NPD5762 |
Approved |
0.7134 |
Intermediate Similarity |
NPD5763 |
Approved |
0.7108 |
Intermediate Similarity |
NPD7003 |
Approved |
0.7102 |
Intermediate Similarity |
NPD6746 |
Phase 2 |
0.7099 |
Intermediate Similarity |
NPD6653 |
Approved |
0.7098 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.7083 |
Intermediate Similarity |
NPD7212 |
Phase 2 |
0.7083 |
Intermediate Similarity |
NPD7213 |
Phase 3 |
0.7083 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.7081 |
Intermediate Similarity |
NPD943 |
Approved |
0.7081 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7081 |
Intermediate Similarity |
NPD1240 |
Approved |
0.7081 |
Intermediate Similarity |
NPD4140 |
Approved |
0.7079 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7076 |
Intermediate Similarity |
NPD8158 |
Clinical (unspecified phase) |
0.707 |
Intermediate Similarity |
NPD3266 |
Approved |
0.707 |
Intermediate Similarity |
NPD3267 |
Approved |
0.7059 |
Intermediate Similarity |
NPD920 |
Approved |
0.7041 |
Intermediate Similarity |
NPD7585 |
Approved |
0.7041 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.7041 |
Intermediate Similarity |
NPD7422 |
Clinical (unspecified phase) |
0.7041 |
Intermediate Similarity |
NPD7447 |
Phase 1 |
0.7037 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7033 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.7032 |
Intermediate Similarity |
NPD1091 |
Approved |
0.7031 |
Intermediate Similarity |
NPD6780 |
Approved |
0.7031 |
Intermediate Similarity |
NPD6776 |
Approved |
0.7031 |
Intermediate Similarity |
NPD6777 |
Approved |
0.7031 |
Intermediate Similarity |
NPD6781 |
Approved |
0.7031 |
Intermediate Similarity |
NPD6779 |
Approved |
0.7031 |
Intermediate Similarity |
NPD6778 |
Approved |
0.7031 |
Intermediate Similarity |
NPD6782 |
Approved |
0.7024 |
Intermediate Similarity |
NPD6666 |
Approved |
0.7024 |
Intermediate Similarity |
NPD6667 |
Approved |
0.7024 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.7019 |
Intermediate Similarity |
NPD4062 |
Phase 3 |
0.7012 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.701 |
Intermediate Similarity |
NPD4004 |
Approved |
0.701 |
Intermediate Similarity |
NPD4002 |
Approved |
0.7006 |
Intermediate Similarity |
NPD1283 |
Approved |
0.7 |
Intermediate Similarity |
NPD1940 |
Clinical (unspecified phase) |
0.7 |
Intermediate Similarity |
NPD7667 |
Clinical (unspecified phase) |
0.6995 |
Remote Similarity |
NPD7039 |
Approved |
0.6995 |
Remote Similarity |
NPD3452 |
Approved |
0.6995 |
Remote Similarity |
NPD2494 |
Approved |
0.6995 |
Remote Similarity |
NPD3450 |
Approved |
0.6995 |
Remote Similarity |
NPD7038 |
Approved |
0.6995 |
Remote Similarity |
NPD2493 |
Approved |
0.6994 |
Remote Similarity |
NPD1607 |
Approved |
0.699 |
Remote Similarity |
NPD7583 |
Approved |
0.6988 |
Remote Similarity |
NPD5958 |
Discontinued |
0.6988
|
Remote Similarity |
NPD2424 |
Discontinued |